Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. (2006)

Peer-Reviewed Study · Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W et al. · October 8, 2006

Meissner PE et al., 2006-10-08: Burkina Faso 2004 uncontrolled dose-finding study of methylene blue plus chloroquine in 435 young children with uncomplicated falciparum malaria, reporting three serious adverse events (one probably attributable to study medication) and day-14 failure around 10%.

In 2004, an uncontrolled dose-finding study on the combination MB-CQ was performed in 435 young children with uncomplicated falciparum malaria in Burkina Faso

84

Meissner PE et al., 2006-10-08: Burkina Faso 2004 uncontrolled dose-finding study of methylene blue plus chloroquine in 435 young children with uncomplicated falciparum malaria, reporting three serious adverse events (one probably attributable to study medication) and day-14 failure around 10%. C9 Burkina Faso (Malar J 5:84, 2006). Study type: uncontrolled dose-finding study, N=435 children. Oral methylene blue plus chloroquine; doses in the paper (not in abstract captured). Comparator: none (uncontrolled); chloroquine monotherapy had >50% clinical failure in the area in 2003, cited as context. Funder/conflicts not stated. Bearing PARTLY: dose-finding without a control arm, plus a probable drug-attributed serious adverse event. Also filed as MTL-002 (claims C1, C9). Study type: uncontrolled series.